ArticleTobacco induced diseases2026
Association of smoking behaviors with GOLD biological age acceleration and potential mediation: Evidence from NHANES 1999-2023.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe association between smoking and biological age acceleration, such as KDM and PhenoAge, has been reported, but the dose-response relationship between smoking and the acceleration of GOLD biological age remains unclear. This study aims to explore the association between smoking behavior and the acceleration of GOLD biological age, and to assess the potential mediating roles of oxidative stress and inflammation.
methodsThis cross-sectional study used data from 12 cycles of NHANES (1999-2023), a survey with a complex multi-stage probability sampling design, and included eligible participants. Smoking exposure (daily amount and status) was assessed via standardized self-report questionnaires. The outcome, GoldBioAge-BAaccel, was calculated as residuals from regressing GOLD biological age on chronological age. Multivariable linear regression and restricted cubic splines were applied to evaluate associations, with subgroup analyses stratified by sex, age, and other covariates, and Wald tests for interaction. Sensitivity analyses were performed to test robustness, and mediation analyses explored the mediating effects of uric acid and C-reactive protein.
resultsThe study included 12941 eligible participants. In multivariable linear regression models, each additional cigarette smoked per day was associated with a 0.0763-year increase in BAaccel (β=0.0763; 95% CI: 0.0522-0.1003). Compared with never smokers, current smokers had a 1.5387-year higher BAaccel (β=1.5387; 95% CI: 1.1197-1.9577). Restricted cubic spline analysis showed no evidence of a nonlinear association between CPD and BAaccel (p for nonlinearity=0.285). The association between current smoking and BAaccel differed significantly by age group (p for interaction=0.019). The findings remained consistent across multiple sensitivity analyses. CRP and UA mediated 14.88% and 5.10% of the total effect between daily smoking amount and BAaccel, respectively; for current smoking status (vs never smoking), the corresponding mediated proportions were 9.19 % and 2.40%.
conclusionsSmoking behavior is positively associated with GOLD biological age acceleration, and this association is partially mediated by systemic inflammation and oxidative stress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.